Oakdale, LA (PRWEB) July 30, 2009
John Stigall, CEO of Oakdale Community Hospital in Oakdale, Louisiana, announced recently that the hospital is offering a new treatment, Reclast, for the prevention of osteoporosis in women.
Reclast (zoledronic acid) is the only FDA approved, once a year treatment for postmenopausal osteoporosis. The procedure consists of an IV infusion that lasts around 15 minutes. Used along with daily calcium and vitamin D, Reclast helps protect bones for up to 12 months.
Oakdale Community Hospital offers resort-like service to patients at its state-of-the-art facility, designed to enhance the care of the women in the central Louisiana region. In addition to hiring staff members based on a caring and customer-service oriented personality as well as skills, the hospital has undergone an extensive upgrade of its physical plant, making it one of the most attractive healthcare facilities in central Louisiana.
Oakdale also ranks among the top hospitals for cleanliness and low infection rates and was recently recognized for its outstanding patient care. In a national survey, the hospital ranked number one in patient satisfaction out of over 300 hospitals polled across the country.
Women who are interested in making an appointment for the new Reclast treatment or would like further information on the procedure should contact Becky Johnson, RN, Education Director for Oakdale at 318-335-4445 or 318-215-3255 (voicemail).
About Oakdale Community Hospital
Oakdale Community Hospital strives to achieve an unequaled level of measurable quality and productivity in the delivery of health services that are responsive to the needs and values of patients, physicians, employers and employees in the communities it serves. Oakdale believes that working in a hospital and serving the patients, families, physicians and each other is a privilege, and patients who visit the hospital enjoy a level of service parallel to that found in a five star hotel.